Human Placental Protein Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | 5.00 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Human Placental Protein Market Analysis
The Human Placental Protein Market is expected to register a CAGR of around 5% during the forecast period. Rising use of placental protein in cosmetics and medication to treat menopause is among the key factor triggering the growth of the human placental protein market. For instance, several products are in the human placental market which is promoting the revenue growth, Melsmon pharmaceuticals are producing pharmaceutical-grade placenta which is used for treating menopause. In addition, Japan Bio Products has Laennec which treats chronic hepatitis and another company Alber David has Inj.Placentrex. (wound healer).
The increase in R&D investments in healthcare coupled with the introduction of human placental protein in pseudo-medicines will create lucrative opportunities in the human placental protein market.
However, prolonged use of human placental proteins can cause skin dryness which hampers the market.
Human Placental Protein Market Trends
This section covers the major market trends shaping the Human Placental Protein Market according to our research experts:
Skin Care Products in Human Placental Protein Segment is Expected to Hold Significant Market Share
Skin Care Products are expected to dominate the global human placental protein market in the forecast period. This can be attributed to the rising prevalence of cosmetics products among the targeted population and the increasing number of menopause population. As the placenta connects developing fetus to the uterine wall to all nutrients uptake, thermoregulation, fighting against internal infection and produce hormones to support pregnancy, which makes placenta protein highly nutritious and thus it further hydrolyzed and use it for many skincare products and hair care treatments.
In addition, with the increasing aging population worldwide, the human placental protein extract has been extensively used for anti-aging therapy and is promoting the growth of the overall market.
North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period
North America is expected to hold a significant market share in the global Human Placental Protein market attributing to an increasingly aging population with a higher rate of menopause population in this region. According to the National Institute of Health, approximately 1.3 million women become menopausal each year and 5% experience early menopause in the United States. This is leading to the adoption of placental extract for treating menopausal, thus promote the growth of the human placental protein market. Furthermore, increasing healthcare expenditure and the presence of well-established healthcare infrastructure is also fueling the growth of the overall regional market to a large extent.
Human Placental Protein Industry Overview
The market studied is moderately competitive and most of the companies operating in the market are the local players from various countries. Some of the companies which are currently getting the attention in the market are JAPAN BIO PRODUCTS Co., Ltd., VWR International, Takara Bio Inc, Abcam plc, Kamiya Biomedical Co, Scripps Laboratories, Lee BioSolutions and elabscience.
Human Placental Protein Market Leaders
-
Takara Bio Inc
-
VWR International
-
Scripps Laboratories
-
Lee BioSolutions
-
JAPAN BIO PRODUCTS Co.
*Disclaimer: Major Players sorted in no particular order
Human Placental Protein Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Increasing use of Cosmetics Products
- 4.2.2 Increasing Ageing Population
-
4.3 Market Restraints
- 4.3.1 Adverse Effects
-
4.4 Porter's Five Force Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
-
5.1 By Type
- 5.1.1 Hydrolyzed Human Placental Protein
- 5.1.2 Human Placental Enzymes
- 5.1.3 Others
-
5.2 By Application
- 5.2.1 Tumor markers
- 5.2.2 Life sciences
- 5.2.3 Others
-
5.3 Geography
- 5.3.1 North America
- 5.3.1.1 United States
- 5.3.1.2 Canada
- 5.3.1.3 Mexico
- 5.3.2 Europe
- 5.3.2.1 Germany
- 5.3.2.2 United Kingdom
- 5.3.2.3 France
- 5.3.2.4 Italy
- 5.3.2.5 Spain
- 5.3.2.6 Rest of Europe
- 5.3.3 Asia-Pacific
- 5.3.3.1 China
- 5.3.3.2 Japan
- 5.3.3.3 India
- 5.3.3.4 Australia
- 5.3.3.5 South Korea
- 5.3.3.6 Rest of Asia-Pacific
- 5.3.4 Middle-East and Africa
- 5.3.4.1 GCC
- 5.3.4.2 South Africa
- 5.3.4.3 Rest of Middle-East and Africa
- 5.3.5 South America
- 5.3.5.1 Brazil
- 5.3.5.2 Argentina
- 5.3.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 JAPAN BIO PRODUCTS Co., Ltd.
- 6.1.2 VWR International
- 6.1.3 Takara Bio Inc
- 6.1.4 Abcam plc
- 6.1.5 Kamiya Biomedical Co.
- 6.1.6 Scripps Laboratories
- 6.1.7 Lee BioSolutions
- 6.1.8 elabscience
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityHuman Placental Protein Industry Segmentation
As per the scope, Human placental protein includes protein derived from human placentas used in several applications such as luteotropic, lactogenic, cosmetics and growth-promoting action. Human Placental Protein Market is segmented By Type, Application, and Geography.
| By Type | Hydrolyzed Human Placental Protein | |
| Human Placental Enzymes | ||
| Others | ||
| By Application | Tumor markers | |
| Life sciences | ||
| Others | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| Geography | Middle-East and Africa | GCC |
| South Africa | ||
| Rest of Middle-East and Africa | ||
| Geography | South America | Brazil |
| Argentina | ||
| Rest of South America |
Human Placental Protein Market Research FAQs
What is the current Human Placental Protein Market size?
The Human Placental Protein Market is projected to register a CAGR of less than 5% during the forecast period (2024-2029)
Who are the key players in Human Placental Protein Market?
Takara Bio Inc, VWR International, Scripps Laboratories, Lee BioSolutions and JAPAN BIO PRODUCTS Co. are the major companies operating in the Human Placental Protein Market.
Which is the fastest growing region in Human Placental Protein Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Human Placental Protein Market?
In 2024, the North America accounts for the largest market share in Human Placental Protein Market.
What years does this Human Placental Protein Market cover?
The report covers the Human Placental Protein Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Human Placental Protein Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
South Africa Respiratory Devices Industry Report
Statistics for the 2024 South Africa Respiratory Devices market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. South Africa Respiratory Devices analysis includes a market forecast outlook 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
